1-5 of 5
Juan Carlos Hernandez Boluda, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results from Fight-203, a Phase 2, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Pemigatinib (INCB054828) in Patients with Myeloid/Lymphoid Neoplasms with Rearrangement of Fibroblast Growth Factor Receptor 1 ( FGFR1 )

Srdan Verstovsek, MD PhD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD PhD, Jason R. Gotlib, MDMS, Adam J. Mead, MD PhD, Andreas Hochhaus, MD, Jean-Jacques Kiladjian, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Ekaterine Asatiani, MD, Christine Lihou, BS, Huiling Zhen, MD PhD, Andreas Reiter, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 690.
https://doi.org/10.1182/blood-2018-99-110388
Published: 2018
Journal Articles

Triple Negative Myelofibrosis and Myelodysplastic Syndrome with Fibrosis: Clinico-Biological Characterization and Correlation with Gene Mutations

Juan Gonzalo Correa, MD, Alberto Alvarez-Larrán, MD PhD, Monica Lopez-Guerra, PhD, Juan Carlos Hernandez Boluda, MD PhD, Mar Tormo, MD PhD, María Rozman, MD PhD, Daniel Martínez, MD, Dolors Colomer, PhD, Jordi Esteve, MD PhD, Francisco Cervantes, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4299.
https://doi.org/10.1182/blood-2018-99-115888
Published: 2018
Journal Articles

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Juan Carlos Hernandez Boluda, MD PhD, Arturo Pereira, MD PhD, Irene Pastor-Galán, MDcal Doctor, Alberto Alvarez-Larrán, MD PhD, Alisa Savchuk, Jose Manuel Puerta, Jose M. Sanchez, Rosa Collado, Álvaro Díaz, Anna Angona, MD PhD, Miguel Sagüés, Valentín García Gutiérrez, PhD, Concepcion Boque, MD PhD, Ignacio Gómez-Centurión, MD, Rolando Vallansot, MD, Luis Palomera, MD PhD, Arantxa Mendizábal, Luis Felipe Casado, MD, Manuel Pérez-Encinas, Raul Perez Lopez, Francisca Ferrer Marin, MD PhD, Fermin Sanchez-Guijo, MD PhD, Carmen Garcia-Hernandez, MD, Natalia de las Heras, Jose Luiz Lopez Lorenzo, MD, Francisco Cervantes, MD PhD, Juan Luis Steegmann, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 47.
https://doi.org/10.1182/blood-2018-99-109976
Published: 2018
Journal Articles

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Francisca Ferrer Marin, MD PhD, Ana Belen F Arroyo, PhD, Beatriz Bellosillo, PhD, Lurdes Zamora, PhD, Ana Kerguelen Fuentes, MD PhD, Patricia Vélez, MD, Elisa Luño, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Rosa Ayala, MD PhD, Dolly Viviana Fiallo, MD, Jose Valentín García Gutiérrez, MD PhD, Beatriz Arrizabalaga, MD PhD, María Teresa Gómez-Casares, MD PhD, Concepcion Boque, MD PhD, Carmen Garcia-Hernandez, MD, Jesús María Hernández-Rivas, MD PhD, Carles Besses, MD PhD, Vicente Vicente, MD PhD, Alberto Alvarez-Larrán, MD PhD, Raul Teruel Montoya, PhD, Rocio González-Conejero, PhD, Constantino Martínez, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3072.
https://doi.org/10.1182/blood-2018-99-119221
Published: 2018
Journal Articles

Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Arturo Pereira, MD PhD, Carlos Besses Raebel, MD PhD, Juan Carlos Hernandez Boluda, MD PhD, Francisca Ferrer Marin, MD PhD, Carmen Garcia-Hernandez, MD, María Teresa Gómez-Casares, MD PhD, Manuel Pérez-Encinas, MD, María-Soledad Noya, MD, Beatriz Cuevas, MD, Gonzalo Caballero, MD, Maribel Mata, Francisco Cervantes, MD PhD, Alberto Alvarez-Larrán, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3042.
https://doi.org/10.1182/blood-2018-99-109892
Published: 2018